TickerStat.com

NOVAVAX INC (NVAX)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$1.12B$682.2M$983.7M$1.98B$1.15B$475.6M$18.7M$34.3M$31.2M$15.4M$36.3M$30.7M$20.9M$22.1M$14.7M$343,000—
Research & development$342.3M$391.2M$737.5M$1.24B$2.53B$747.0M$113.8M$173.8M$168.4M$237.9M$162.6M$94.4M$58.5M$26.9M$18.4M$28.0M$25.8M
Operating income$452.8M−$248.9M−$566.5M−$644.7M−$1.69B−$416.7M−$120.6M−$173.9M−$171.7M−$269.1M−$157.2M−$83.7M−$52.4M−$29.7M−$21.6M−$38.5M−$37.4M
EBITDAderived$480.8M−$200.9M−$525.5M−$615.7M−$1.67B−$412.4M−$115.5M−$166.5M−$164.1M−$261.4M−$152.1M−$79.3M−$49.8M−$28.0M−$20.0M−$37.1M−$36.2M
Net income$440.3M−$187.5M−$545.1M−$657.9M−$1.74B−$418.3M−$132.7M−$184.7M−$183.8M−$280.0M−$156.9M−$82.9M−$52.0M−$28.5M−$19.4M−$35.7M−$40.3M
Basic EPSper diluted share$2.72-$1.23-$5.41-$8.42-$23.44-$7.27-$5.51-$9.99-$12.56-$1.03-$0.60-$0.37-$0.31-$0.22-$0.17-$0.34-$0.47
Diluted EPSper diluted share$2.58-$1.23-$5.41-$8.42-$23.44-$7.27-$5.51-$9.99-$12.56-$1.03-$0.60-$0.37-$0.31-$0.22-$0.17-$0.34-$0.47
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)3$119.6K disclosed value
3 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 31, 2024Form 4YOUNG JAMES FDirectorSellCommon Stock5.4K$8.00$43.2K51.8K
Dec 24, 2024Form 4YOUNG JAMES FDirectorSellCommon Stock4.6K$8.48$39.0K57.2K
Dec 13, 2024Form 4King Rachel K.DirectorSellCommon Stock4.2K$9.02$37.4K14.8K
Review ownership filings at SEC.gov ↗